RSV

Healthcare

RSV Vaccines Lose Some Shine for Big Pharma

Photo by Mathurin Napoly via Unsplash

Pfizer, Moderna, and GlaxoSmithKline are developing vaccines for RSV to fill the gap on their balance sheets.

1 min read

Photo by Paloma A. via Unsplash

Consumer

Will the Drink Industry’s Hangover Last Through 2025?

In a 2023 Gallup survey, 62% of American adults under 35 said they drink alcohol, down from 72% twenty years earlier.

2 min read
Photo by Hank Paul via Unsplash

Media & Entertainment

Will 2025 be the Year Regulation Comes for Sports Betting?

The odds of an increase in regulation of the massive, and growing, sports-betting industry may be shifting.

2 min read
Photo by Chemist4U via CC BY-SA 2.0

Healthcare

2025 is the Year of the Weight Loss Pill

Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.